Arthromac® is an injectable solution designed to treat osteoarthritis by replenishing hyaluronic acid in the synovial fluid. This enhances joint lubrication and shock absorption, providing a quick, powerful and long-lasting relief from pain and stiffness.
Manufactured in Europe with non-animal, ultrapure, high molecular weight French-origin HA, naturally cross-linked without any chemical agents.
The benefits of Arthromac®
-
Arthromac products are made from a high molecular weight hyaluronic acid from French origin with the highest level purity available in the industry today.
-
Arthromac products are produced in Europe under the highest quality standards with a rigorous control of the manufacturing process.
-
Arthromac products are cross-linked through a proprietary technology called X-Click Technology without any chemical agents. As a result, the gel is fully compatible, with unaltered viscoelastic and biological properties.
-
The HA in Arthromac has a molecular weigth between 3 and 4 millions Dalton, providing a better effectiveness compared to products with lower molecular weight.
Arthromac® in action
The injection of Arthromac® will provide three main actions:
Quickly and lastingly relieves joint pain
Decreases stiffness for more mobility
Protects cartilage against degradation
Our proprietary cross-linking process X-Click technology™ makes it possible to transform linear HA into a stabilized 3D HA without any chemical agents.
As a result, the injected HA will have a greater residence time in the joint while keeping its natural biological and rheological properties for more effectiveness and a complete safety.
A physical cross-linking
The laboratory
Astagen Therapeutics® is a French origin company specialised in the research and development of innovative products useful in the prevention and treatment of tissue aging.
Astagen® brands